The Verte Opportunity Zone Fund, Inc (of College Park, MD) has made an investment in the MDC Studio-Baltimore. The Studio was recently formed by the MDC Partnership as a platform for expansion and investment. The Studio houses all of MDC’s current companies.
Sanaria Receives Substantial Investment from EU Malaria Fund
Graybug Vision files for $86 Million IPO on NASDAQ (GRAY)
Perhaps the single biggest challenge faced by startup entrepreneurs and early-stage life science companies is securing the necessary funding to fuel innovation and growth. The BioHealth Capital Region (BHCR) life science community as a whole faces a similar challenge when it comes to access to venture capital funding; this challenge has been noted by many BHCR thought leaders and well-documented in a host of BioBuzz stories.
BioHealth Innovation (BHI) was created in 2012 by Rich Bendis and key industry leaders to accelerate the commercialization of high potential scientist entrepreneurs and companies within the BioHealth Capital Region (BHCR), which consists of Maryland, Virginia and Washington, D.C.
Bryan Poltilove is a Managing Director focused on guiding BroadOak’s growth capital investing strategy and advising portfolio companies in the life sciences and cell and gene therapy sectors.
Emergent BioSolutions to Invest $75 Million in Canton Site and Expand Viral Vector and Gene Therapy Capability
Emergent BioSolutions to Invest $75 Million in Canton Site and Expand Viral Vector and Gene Therapy Capability June 18, 2020 Company acquires property adjacent to its Canton, Massachusetts live viral [….]
VCs Cautious of “COVID-19 Contortionists” and Telemedicine “Gold Rush” COVID-19 is fundamentally changing how we live, how we do business, and how we approach and deliver our healthcare. In the [….]
BioHealth Capital Region Startups Raised More Than $739M in 2019 These 15 Biohealth Startups had a Banner Year, Setting Themselves Up for Success in 2020 The startup ecosystem in the [….]
Five Female Investors Who Are Making Their Mark in Life Science November 26, 2019 Less than 10% of decision-makers at U.S. venture capital (VC) firms are women and a whopping [….]